Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy

Cell Communication and Adhesion

Volumn 21, Issue 1, 2014, Pages 13-23

  Asimaki, Angeliki ^a   Saffitz, Jeffrey E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Arrhythmias; Cardiomyopathy; Cell cell adhesion; Desmosomes

Indexed keywords

PLAKOGLOBIN;

ARRHYTHMOGENIC CARDIOMYOPATHY; AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CELL JUNCTION; CELL SIGNALING ASSAY; DESMOSOME; EXPERIMENTAL MODEL; GENE MUTATION; GENETICS; HEART MUSCLE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MYOCARDIAL DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION;

ANIMALS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DESMOPLAKINS; DESMOSOMES; DISEASE MODELS, ANIMAL; GAMMA CATENIN; HUMANS; INTERCELLULAR JUNCTIONS; VENTRICULAR REMODELING;

EID: 84897006490     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2013.876016     Document Type: Review

References (72)

1. Asimaki A, Saffitz JE (2012). Gap junctions and arrhythmogenic cardiomyopathy. Heart Rhythm. 9 : 992-995.
2. Asimaki A, Tandri H, Duffy ER, Winterfield J.R., Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE (2011). Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 4 : 743-752.
3. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE (2009). A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 360 : 1075-1084.
4. Basso C, Czarnowska E, Della Barbera M, Bauce B, Beffagna G, Wlodarska EK, Pilichou K, Ramondo A, Lorenzon A, Wozniek O, Corrado D, Datiento L, Danieli GA, Valente M, Nava A, Thiene G, Rampazzo A (2006). Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. Eur Heart J. 27 : 1847-1854.
5. Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G, Malacrida S, Settimo L, Danieli G, Thiene G, Nava A (2005). Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 26 : 1666-1675.
6. Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, Danieli GA, Rampazzo A (2005). Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 65 : 366-373.
7. Bengtsson L, Otoo H (2008). LUMA interacts with emerin and influences its distribution at the inner nuclear membrane. J Cell Sci. 121 : 536-548.
8. Bierkamp C, Mclaughlin KJ, Schwarz H, Huber O, Kemler R (1996). Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol. 180 : 780-785.
9. Borjesson M, Pelliccia A (2009). Incidence and aetiology of sudden cardiac death in young athletes: an international perspective. Br J Sports Med. 43 : 644-648.
10. Carvajal-Huerta L (1998). Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol. 39 : 418-421
11. Cerrone M, Noorman M, Lin X, Chkourko H, Liang FX, van der Nagel R, Hund T, Birchmeier W, Mohler P, van Veen TA, van Rijen HV, Delmar M (2012). Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency. Cardiovasc Res. 95 : 460-468.
12. Christensen AH, Andersen CB, Tybjaerg-Hansen A, Haunso S, Svendsen JH (2011). Mutation analysis and evaluation of the cardiac localization of TMEM43 in arrhythmogenic right ventricular cardiomyopathy. Clin Genet. 80 : 256-264.
13. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, Otter MI, Murday VA, Mattu RK, McKenna WJ (1998). Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation. 97 : 2049-2058.
14. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Jama-J Am Med Assoc. 296 : 1593-1601.
15. Corrado D, Basso C, Thiene G (2000). Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart. 83 : 588-595.
16. Delmar M (2012). Desmosome- ion channel interactions and their possible role in arrhythmogenic cardiomyopathy. Pediatr Cardiol. 33 : 975-979.
17. Deo M, Sato PY, Musa H, Lin X, Pandit SV, Delmar M, Berenfeld O (2011). Relative contribution of changes in sodium current versus intercellular coupling on reentry initiation in 2-dimensional preparations of plakophilin- 2-deficient cardiac cells. Heart Rhythm. 8 : 1740-1748.
18. Gallicano GI, Kouklis P, Bauer C, Yin M, Vasioukhin V, Degenstein L, Fuchs E (1998). Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol. 143 : 2009-2022.
19. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest. 116 : 2012-2021.
20. Grossmann KS, Grund C, Huelsken J, Behrend M, Erdmann B, Franke WW, Birchmeier W (2004). Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol. 167 : 149-160.
21. Haghighi K, Kolokathis F, Gramolini AO, Waggoner J.R., Pater L, Lynch RA, Fan GC, Tsiapras D, Parekh RR, Dorn GW II, MacLennan DH, Kremastinos DT, Kranias EG (2006). A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc Natl Acad Sci U S A. 103 : 1388-1393.
22. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, Gramolini AO, Fan GC, Tsiapras D, Hahn HS, Adamopoulos S, Liggett SB, Dorn GW, MacLennan DH, Kremastinos DT, Kranias E (2003). Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest. 111 : 869-876.
23. Hariharan V, Provost J, Shah S, Konofagou E, Huang H (2012). Elevated strain and structural disarray occur at the right ventricular apex. Cardiovas Eng Technol. 3 : 52-61.
24. Hatsell S, Medina L, Merola J, Haltiwanger R, Cowin P (2003). Plakoglobin is O-glycosylated close to the N-terminal destruction box. J Biol Chem. 278: 37745-37752.
25. Huang H, Asimaki A, Lo D, McKenna W, Saffitz J (2008). Disparate effects of different mutations in plakoglobin on cell mechanical behavior. Cell Motil Cytoskeleton. 65 : 964-978.
26. Kaplan S.R., Gard JJ, Carvajal-Huerta L, Ruiz-Cabezas JC, Thiene G, Saffitz JE. (2004a). Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol. 13 : 26-32.
27. Kaplan S.R., Gard JJ, Protonotarios N, Tsatsopoulou A, Spiliopoulou C, Anastasakis A, Squarcioni CP, McKenna WJ, Thiene G, Basso C, Brousse N, Fontaine G, Saffitz JE. (2004b). Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm. 1 : 3-11.
28. Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, Hauer RN, van Tintelen JP, Jongbloed JD, Calkins H, Judge DP, Wilde AA, Ackerman MJ (2011). Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol. 57 : 2317-2327.
29. Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS (2013). Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 494 : 105-110.
30. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B (2006). Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobindeficient mice. Circulation. 114 : 1799-1806.
31. Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, Marian AJ (2011). Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res. 109 : 1342-1353.
32. Lyon RC, Mezzano V, Wright AT, Pfeiffer E, Chuang J, Banares K, Castaneda A, Ouyang K, Cui L, Contu R, Gu Y, Evans SM, Omens JH, Peterson KL, McCulloch AD, Sheikh F (2013). Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum Mol Genet. [Epub ahead of print]
33. MacLennan DH, Kranias EG (2003). Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol. 4 : 566-577.
34. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation. 121: 1533-1541.
35. Marks AR, Priori S, Memmi M, Kontula K, Laitinen PJ (2002). Involvement of the cardiac ryanodine receptor/ calcium release channel in catecholaminergic polymorphic ventricular tachycardia. J Cell Physiol. 190 : 1-6.
36. McKenna WJ, Thiene G, Nava A, Fontaliron F, Blomstrom- Lundquist G, Fontaine G, Camerini F; on behalf of the Task Force of the working group myocardial and pericardial disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology (1994). Diagnosis of arrhythmogenic right ventricular dysplasia cardiomyopathy. Br Heart J. 71 : 215-218.
37. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, Norman M, Baboonian C, Jeffery S, McKenna WJ (2000). Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355 : 2119-2124.
38. Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, McKenna W, Gallagher B, Morris-Larkin L, Bassett AS, Parfrey PS, Young TL (2008). Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 82 : 809-821.
39. Nava A, Scognamiglio R, Thiene G, Canciani B, Daliento L, Buja G, Stritoni P, Fasoli G, Dalla Volta S (1987). A polymorphic form of familial arrhythmogenic right ventricular dysplasia. Am J Cardiol. 59 : 1405-1409.
40. Noorman M, Hakim S, Kessler E, Groeneweg JA, Cox MG, Asimaki A, van Rijen HV, van Stuijvenberg L, Chkourko H, van der Heyden MA, Vos MA, de Jonge N, van der Smagt JJ, Dooijes D, Vink A, de Weger RA, Varro A, de Bakker JM, Saffitz JE, Hund TJ, Mohler PJ, Delmar M, Hauer RN, van Veen TA (2013). Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm. 10 : 412-419.
41. Norman M, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P, Sen-Chowdhry S, Rowland E, Crosby A, McKenna WJ (2005). Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 112 : 636-642.
42. Otten E, Asimaki A, Maass A, van Langen IM, van der Wal A, de Jonge N, van den Berg MP, Saffitz JE, Wilde AA, Jongbloed JD, van Tintelen JP (2010). Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm. 7 : 1058-1064.
43. Pilichou K, Remme CA, Basso C, Campian ME, Rizzo S, Barnett P, Scicluna BP, Bauce B, van den Hoff MJ, de Bakker JM, Tan HL, Valente M, Nava A, Wilde AA, Moorman AF, Thiene G, Bezzina CR (2009). Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 206: 1787-1802.
44. Polychronopoulou S, Tsatsopoulou A, Papadhimitriou SI, Panagiotou JP, Anastasakis A, Paterakis G, Anagnostou D, Protonotarious N, Haidas SA (2002). Myelodysplasia and Naxos disease: a novel pathogenetic association? Leukemia. 16 : 2335-2337.
45. Posch MG, Perrot A, Geier C, Boldt LH, Schmidt G, Lehmkuhl HB, Hetzer R, Dietz R, Gutberlet M, Haverkamp W, Ozcelik C (2009). Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes. Heart Rhythm. 6 : 480-486.
46. Purkis PE, Whittock N, Leigh IM, Stevens HP, Kelsell DP (2000). Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet. 9 : 2761-2766.
47. Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G (1994). The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 3 : 959-962.
48. Rampazzo A, Nava A, Malacrida S, Beffagna G, Bauce B, Rossi V, Zimbello R, Simionati B, Basso C, Thiene G, Towbin JA, Danieli GA (2002). Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 71 : 1200-1206.
49. Rizzo S, Lodder EM, Verkerk AO, Wolswinkel R, Beekman L, Pilichou K, Basso C, Remme CA, Thiene G, Bezzina CR (2012). Intercalated disc abnormalities, reduced Na (+) current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes. Cardiovasc Res. 95 : 409-418.
50. Romero J, Mejia-Lopez E, Manrique C, Lucariello R (2013). Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): a systematic literature review. Clin Med Ins Cardiol. l 7 : 97-114.
51. Rubenstein A, Merriam J, Klymkowsky MW (1997). Localizing the adhesive and signaling functions of plakoglobin. Dev Genet. 20 : 91-102.
52. Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A (2000). Differential interaction of plakoglobin and ® -catenin with the ubiquitin-proteasome system. Oncogene. 19 : 1992-2000.
53. Saffitz JE (2003). Dependence of electrical coupling on mechanical coupling in cardiac myocytes. In: Thiene G, Dessina AC (eds). Advances in Cardiovascular Medicine. Padua, Italy: Universit á degli Studi di Padova. pp. 15-28.
54. Saffitz JE, Asimaki A, Huang H (2010). Arrhythmogenic right ventricular cardiomyopathy: new insights into mechanisms of disease. Cardiovasc Pathol. 19 : 166-170.
55. Saffitz JE, Asimaki A, Huang H (2009). Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis. J Investig Med. 57 : 861-864.
56. Saffitz JE (2009). Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling. Heart Rhythm. 8: S62-S65.
57. Saffitz JE (2011). The pathobiology of arrhythmogenic cardiomyopathy. Annu Rev Pathol. 6: 299-321.
58. Sato PY, Coombs W, Lin XM, Nekrasova O, Green KJ, Isom LL, Taffet SM, Delmar M (2011). Interactions between ankyrin-g, plakophilin-2, and connexin43 at the cardiac intercalated disc. Circ Res. 109 : 193-U160.
59. Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patino GA, Taffet SM, Isom LL, Delmar M (2009). Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res. 105 : 523-526.
60. Schmitt JP, Kamisago M, Asahi M, Li GH, Ahmad F, Mende U, Kranias EG, MacLennan DH, Seidman JG, Seidman CE (2003). Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 299 : 1410-1413.
61. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ (2010). Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med. 61 : 233-253.
62. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ (2007). Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/ cardiomyopathy provides novel insights into patterns of disease expression. Circulation. 115 : 1710-1720.
63. Shen WK, Edwards WD, Hammill SC, Gersh BJ (1994). Right ventricular dysplasia: a need for precise pathological definition for interpretation of sudden death. Am Coll Cardiol. 23 : 34A.
64. Tabib A, Loire R, Chalabreysse L, Meyronnet D, Miras A, Malicier D, Thivolet F, Chevalier P, Bouvagnet P (2003). Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/ or dysplasia. Circulation. 108 : 3000-3005.
65. Thiene G, Corrado D, Basso C (2007). Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis. 2 : 45-61.
66. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988). Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 318 : 129-133.
67. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, Muriago M, Basso C, Thiene G, Danieli GA, Rampazzo A (2001). Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 10 : 189-194.
68. van de Schans VA, Smits JF, Blankesteijn WM (2008). The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol. 585 : 338-345.
69. van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck- Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP (2012). Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 14 : 1199-1207.
70. van Tintelen JP, Entius MM, Bhuiyan ZA, Jongbloed R, Wiesfeld AC, Wilde AA, van der Smagt J, Boven LG, Mannens MM, van Langen IM, Hofstra RM, Otterspoor LC, Doevendans PA, Rodriguez LM, van Gelder IC, Hauer RN (2006). Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation. 113 : 1650-1658.
71. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA; Multidisciplinary Study of Right Ventricular Dysplasia Investigators (2010). Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 55: 587-597.
72. Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, Nadvoretskiy VV, DeFreitas G, Carabello B, Brandon LI, Godsel LM, Green KJ, Saffitz JE, Li H, Danieli GA, Calkins H, Marcus F, Towbin JA (2006). Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circ Res. 99 : 646-655.